How to Hack a $1.3T Market

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

Surbhi Jain
July 25, 2025

Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s (NASDAQ:PLTR) Foundry platform, showcasing data transparency and precision that would make legacy pharma pipelines look prehistoric.

Track Palantir’s stock moves here.

Down the hall, Tempus AI Inc (NASDAQ:TEM) had its own room, where genomics-powered diagnostics promised to cut months off drug development timelines. Across the corridor, Recursion Pharmaceuticals Inc (NASDAQ:RXRX), bolstered by NVIDIA Corp's (NASDAQ:NVDA) AI horsepower, quietly toiled in labs, churning out molecules faster than traditional researchers.

This isn't science fiction -- it's a 2025 investment frontier, and the numbers tell the story.

Read Also: Palantir Won Pentagon--Next Target: Fortune 500

Palantir's stock is up nearly 10 % month-to-date and has gone even higher year-to-date, as bullish sentiment surges ahead of its second quarter earnings.

Tempus AI shares, currently at about $64, have held firm despite a roughly 6 % pullback over the past month, reflecting investor confidence in its diagnostics platform.

Recursion, trading around $6, has surged nearly 15 % since late June, even while still down roughly 10 % year-to-date, signaling renewed optimism in its AI‑assisted drug discovery pipeline.

Meanwhile, Big Pharma remains stuck in neutral. Pfizer Inc (NYSE:PFE) trades around $24.70 and Merck & Co Inc (NYSE:MRK) at $84.49, both meandering with little buzz from investors. Despite coughing up solid revenue, legacy firms are fighting uphill battles with patent cliffs, rising price scrutiny and slowing innovation cycles.

In contrast, these AI-native players are redefining the narrative: Palantir sells the data architecture hospitals didn't know they needed; Tempus packages AI into actionable diagnostics; Recursion blends machine learning and molecular libraries faster than old-school pharma can. Together, they're disrupting drug discovery, trial design, and clinical decision-making -- and attracting capital accordingly.

Big Pharma's comeback story may yet unfold -- but right now, the buzz is all in AI-lab corridors, not corner offices.

The question for investors: are traditional drugmakers merely behind schedule -- or destined to become the dinosaur era in healthcare?

Read Next:

  • Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer’s Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs

Photo: jittawit21 via Shutterstock

Continue Reading...

Popular

Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'

President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.

Palantir's AI Is Going Physical - Ad

The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.

Draganfly Stock Is Moving Higher Wednesday: What's Going On?

Dragonfly shares are trading higher Wednesday after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Mark Cuban Praised His 'Hustling' Son, But Told Kids: 'Figure Out Who You Are, You Don't Need To Follow In My Footsteps'

Jake Cuban embarked on an entrepreneurial journey reminiscent of his father's early business ventures by starting a side hustle selling candy at his school.

Drone attacks on oil fields in Iraq's Kurdish region shut down another facility

BAGHDAD (AP) — Drones targeted Wednesday, the latest in a series of attacks in recent days that have put several oil facilities out of commission.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Is Costco Stock Topping Out? Key Price Levels To Watch

Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008

A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.

Inside the high-stakes battle to win a New York City casino license

NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Oklo Stock Hit A New 52-Week High Today: What's Driving The Action?

Shares of advanced nuclear technology company Oklo are trading higher Thursday. The company announced a strategic alliance with Liberty Energy on Wednesday.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal

TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .

Tesla Stock Falls Over 6% Pre-Market After Q2 Miss — Elon Musk Warns Of 'Rough Few Quarters' Ahead

Tesla stock falls more than 6% pre-market after Q2 earnings call. Sales decline, EV incentives end, and new Model Y trim disappoints.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Pilot arrested on child sex abuse material charges after landing at San Francisco airport

SAN FRANCISCO (AP) — A pilot was arrested aboard a Delta Air Lines flight and federal agents took him into custody from the cockpit after the plane landed at San Francisco International Airport.

Retirees, here’s how to tweak the 4% rule to protect your nest egg

New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.

Palantir Makes a Move - Now Look At the Chart - Ad

One under-the-radar company just partnered with Palantir to take autonomous security to the next level.

Trump Says Coca Cola Has Agreed To Use Real Cane Sugar In Their US Sodas: 'It's Just Better'

Trump says he's convinced Coca-Cola to use real cane sugar in its U.S. products after discussing with them. It comes amid health concerns of chemicals in products.

Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Cathie Wood Pounces On Tesla Dip: Ark Snaps Up $43.7 Million In EV Stock While Ditching Crypto Shares Amid Bitcoin Frenzy

On Thursday, Cathie Wood-led Ark Invest made significant trades, prominently featuring the purchase of Tesla Inc. (NASDAQ:TSLA) shares across multiple ETFs.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Australian prime minister indulges in panda diplomacy as state visit in China nears end.

BEIJING (AP) — Australian Prime Minister Anthony Albanese has toured a panda breeding facility in the final stages of an extended state visit that has cast China as a fellow champion of a global fair trade system .

Palantir's AI Is Going Physical - Ad

The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Microsoft Raids Google DeepMind To Supercharge AI Copilot, Even As Redmond Cuts 9,000 Jobs Elsewhere: Report

Microsoft has hired around two dozen engineers from Google DeepMind to strengthen its AI team and accelerate Copilot development, intensifying the talent war among tech giants.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright traderelite.club
Privacy Policy | Terms of Service